Literature DB >> 12623857

Theophylline: new perspectives for an old drug.

Peter J Barnes1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623857     DOI: 10.1164/rccm.200210-1142PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  77 in total

1.  Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine.

Authors:  Amir Levine; Yanyou Huang; Bettina Drisaldi; Edmund A Griffin; Daniela D Pollak; Shiqin Xu; Deqi Yin; Christine Schaffran; Denise B Kandel; Eric R Kandel
Journal:  Sci Transl Med       Date:  2011-11-02       Impact factor: 17.956

Review 2.  ABC of chronic obstructive pulmonary disease. Pharmacological management--oral treatment.

Authors:  Graeme P Currie; Daniel K C Lee; Brian J Lipworth
Journal:  BMJ       Date:  2006-06-24

3.  Drugs for asthma.

Authors:  Peter J Barnes
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

4.  Theophylline for COPD.

Authors:  P J Barnes
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

5.  Demographic and Clinical Characteristics of Theophylline Exposures between 1993 and 2011.

Authors:  Nil Hocaoğlu; Engin Yıldıztepe; Başak Bayram; Burç Aydın; Yeşim Tunçok; Şule Kalkan
Journal:  Balkan Med J       Date:  2014-12-01       Impact factor: 2.021

Review 6.  Overcoming gaps in the management of asthma in older patients: new insights.

Authors:  Pranoy Barua; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary disease.

Authors:  Marie-Christyne Cyr; Marie-France Beauchesne; Catherine Lemière; Lucie Blais
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

8.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

9.  Regulated Expression Systems for Mycobacteria and Their Applications.

Authors:  Dirk Schnappinger; Sabine Ehrt
Journal:  Microbiol Spectr       Date:  2014

Review 10.  Adenosine receptors and asthma in humans.

Authors:  C N Wilson
Journal:  Br J Pharmacol       Date:  2008-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.